earnings
confidence high
sentiment neutral
materiality 0.75
CVS Q4 revenue $93.8B (+11.9% YoY), adj. EPS $2.12; FY2024 adj. EPS guidance cut to $8.30
CVS HEALTH Corp
2023-FY EPS reported
$6.47
revenue$357,776,000,000
- Q4 total revenues $93.8B (+11.9% YoY); GAAP diluted EPS $1.58, adjusted EPS $2.12.
- Full-year 2023 revs $357.8B (+10.9%), GAAP EPS $6.47, adj. EPS $8.74; ops cash flow $13.4B.
- FY2024 guidance revised: adj. EPS at least $8.30 (from $8.50), GAAP EPS at least $7.06, ops cash flow $12.0B.
- Quarterly dividend raised 10% effective Feb 1, 2024; $3.1B returned via dividends in 2023.
- Launched CVS CostVantage, Caremark TrueCost pricing models and CVS Healthspire segment for 2025.